Copyright Reports & Markets. All rights reserved.

Global mRNA Vaccine And Therapeutics Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global mRNA Vaccine And Therapeutics Market Status and Forecast (2017-2028)
      • 1.3.2 Global mRNA Vaccine And Therapeutics Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global mRNA Vaccine And Therapeutics Supply by Company

    • 2.1 Global mRNA Vaccine And Therapeutics Sales Value by Company
    • 2.2 mRNA Vaccine And Therapeutics Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional mRNA Vaccine And Therapeutics Market Status by Type

    • 3.1 mRNA Vaccine And Therapeutics Type Introduction
      • 3.1.1 Infectious Disease
      • 3.1.2 Cancer
      • 3.1.3 Others
    • 3.2 Global mRNA Vaccine And Therapeutics Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional mRNA Vaccine And Therapeutics Market Status by Application

    • 4.1 mRNA Vaccine And Therapeutics Segment by Application
      • 4.1.1 Hospital
      • 4.1.2 Research Institual
    • 4.2 Global mRNA Vaccine And Therapeutics Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global mRNA Vaccine And Therapeutics Market Status by Region

    • 5.1 Global mRNA Vaccine And Therapeutics Market by Region
    • 5.2 North America mRNA Vaccine And Therapeutics Market Status
    • 5.3 Europe mRNA Vaccine And Therapeutics Market Status
    • 5.4 Asia Pacific mRNA Vaccine And Therapeutics Market Status
    • 5.5 Central & South America mRNA Vaccine And Therapeutics Market Status
    • 5.6 Middle East & Africa mRNA Vaccine And Therapeutics Market Status

    6 North America mRNA Vaccine And Therapeutics Market Status

    • 6.1 North America mRNA Vaccine And Therapeutics Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe mRNA Vaccine And Therapeutics Market Status

    • 7.1 Europe mRNA Vaccine And Therapeutics Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific mRNA Vaccine And Therapeutics Market Status

    • 8.1 Asia Pacific mRNA Vaccine And Therapeutics Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America mRNA Vaccine And Therapeutics Market Status

    • 9.1 Central & South America mRNA Vaccine And Therapeutics Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa mRNA Vaccine And Therapeutics Market Status

    • 10.1 Middle East & Africa mRNA Vaccine And Therapeutics Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global mRNA Vaccine And Therapeutics Market Forecast by Type and by Application

    • 12.1 Global mRNA Vaccine And Therapeutics Sales Value Forecast (2023-2028)
    • 12.2 Global mRNA Vaccine And Therapeutics Forecast by Type
    • 12.3 Global mRNA Vaccine And Therapeutics Forecast by Application

    13 Global mRNA Vaccine And Therapeutics Market Forecast by Region/Country

    • 13.1 Global mRNA Vaccine And Therapeutics Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Translate Bio
      • 14.1.1 Company Information
      • 14.1.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.1.3 Translate Bio mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Tiba Biotechnology
      • 14.2.1 Company Information
      • 14.2.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.2.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Sangamo Therapeutics
      • 14.3.1 Company Information
      • 14.3.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.3.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Moderna Therapeutics
      • 14.4.1 Company Information
      • 14.4.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.4.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 In-Cell-Art
      • 14.5.1 Company Information
      • 14.5.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.5.3 In-Cell-Art mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Ethris
      • 14.6.1 Company Information
      • 14.6.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.6.3 Ethris mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 eTheRNA
      • 14.7.1 Company Information
      • 14.7.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.7.3 eTheRNA mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 CureVac
      • 14.8.1 Company Information
      • 14.8.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.8.3 CureVac mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 BioNTech
      • 14.9.1 Company Information
      • 14.9.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.9.3 BioNTech mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Argos Therapeutics
      • 14.10.1 Company Information
      • 14.10.2 mRNA Vaccine And Therapeutics Product Introduction
      • 14.10.3 Argos Therapeutics mRNA Vaccine And Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global mRNA Vaccine And Therapeutics market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the mRNA Vaccine And Therapeutics industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global mRNA Vaccine And Therapeutics market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global mRNA Vaccine And Therapeutics Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global mRNA Vaccine And Therapeutics market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global mRNA Vaccine And Therapeutics Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global mRNA Vaccine And Therapeutics industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Infectious Disease
      Cancer
      Others

      Segmented by Application
      Hospital
      Research Institual

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Translate Bio
      Tiba Biotechnology
      Sangamo Therapeutics
      Moderna Therapeutics
      In-Cell-Art
      Ethris
      eTheRNA
      CureVac
      BioNTech
      Argos Therapeutics
      Buy now